Hellstrom PM, Gemmen E, Ward HA, Koo H, et al. Switching from originator infliximab to biosimilar versus continuing on originator in inflammatory bowel disease: results from the observational Project NORTH study. Scand J Gastroenterol 2022 Jul 14:1-8. doi: 10.1080/00365521.2022.2090275.
PMID: 35833832